Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 4, 2022
Distillery Therapeutics

Targeting proBDNF signaling to treat SLE

BioCentury | Oct 11, 2018
Distillery Therapeutics

Cancer

BioCentury | Feb 8, 2016
Finance

Asset renaissance

How Medicxi increases Phase II successes with less capital
BioCentury | Oct 8, 2014
Financial News

Levicept raises L10M series A

BioCentury | Sep 15, 2014
Emerging Company Profile

Levicept: Modulating NGF

Levicept hopes NGF modulator may be disease modifying in osteoarthritis
Items per page:
1 - 10 of 21